Catheter Precision Inc. (NYSE AMERICAN: VTAK) Stock Information | RedChip

Catheter Precision Inc. (NYSE AMERICAN: VTAK) Listen to this Section


$1.58
-0.0337 ( -2.09% ) 7.2K

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Market Data


Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 18 Aug 25, 2023
8-k 8K-related 14 Aug 15, 2023
nt Quarterly Reports 1 Aug 15, 2023
8-k 8K-related 15 Aug 04, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.